Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire

Elisabeth Grobet-Jeandin; Ugo Pinar; Yohann Loriot; Morgan Roupret

Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire

Translated title of the contribution: TREATMENT OF BLADDER CANCER WITH IMMUNE CHECKPOINTS INHIBITORS

Elisabeth Grobet-Jeandin, Ugo Pinar, Yohann Loriot, Morgan Roupret

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Checkpoint inhibitors could lead to a significant improvement in the management of bladder cancer. For metastatic bladder cancer, checkpoint inhibitors showed an improved overall survival and are currently recommended in second intention. Moreover, they could be used in replacement of standard chemotherapy in the case of muscle-invasive tumors. Finally, they appear to decrease the risk of recurrence after initial BCG treatment failure in the case of non-muscle-invasive tumors. For these three diseases forms, numerous ongoing trials are striving to demonstrate checkpoint inhibitors value.

Translated title of the contribution	TREATMENT OF BLADDER CANCER WITH IMMUNE CHECKPOINTS INHIBITORS
Original language	French
Pages (from-to)	391-395
Number of pages	5
Journal	Revue du Praticien
Volume	71
Issue number	4
Publication status	Published - 1 Apr 2021
Externally published	Yes

Cite this

@article{2d06c62c8b73499c85f5e826d6718bfc,

title = "Traitement des tumeurs de la vessie par les inhibiteurs du contr{\^o}le immunitaire",

abstract = "Checkpoint inhibitors could lead to a significant improvement in the management of bladder cancer. For metastatic bladder cancer, checkpoint inhibitors showed an improved overall survival and are currently recommended in second intention. Moreover, they could be used in replacement of standard chemotherapy in the case of muscle-invasive tumors. Finally, they appear to decrease the risk of recurrence after initial BCG treatment failure in the case of non-muscle-invasive tumors. For these three diseases forms, numerous ongoing trials are striving to demonstrate checkpoint inhibitors value.",

author = "Elisabeth Grobet-Jeandin and Ugo Pinar and Yohann Loriot and Morgan Roupret",

year = "2021",

month = apr,

day = "1",

language = "Fran{\c c}ais",

volume = "71",

pages = "391--395",

journal = "Revue du Praticien",

issn = "0035-2640",

number = "4",

}

TY - JOUR

T1 - Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire

AU - Grobet-Jeandin, Elisabeth

AU - Pinar, Ugo

AU - Loriot, Yohann

AU - Roupret, Morgan

PY - 2021/4/1

Y1 - 2021/4/1

N2 - Checkpoint inhibitors could lead to a significant improvement in the management of bladder cancer. For metastatic bladder cancer, checkpoint inhibitors showed an improved overall survival and are currently recommended in second intention. Moreover, they could be used in replacement of standard chemotherapy in the case of muscle-invasive tumors. Finally, they appear to decrease the risk of recurrence after initial BCG treatment failure in the case of non-muscle-invasive tumors. For these three diseases forms, numerous ongoing trials are striving to demonstrate checkpoint inhibitors value.

AB - Checkpoint inhibitors could lead to a significant improvement in the management of bladder cancer. For metastatic bladder cancer, checkpoint inhibitors showed an improved overall survival and are currently recommended in second intention. Moreover, they could be used in replacement of standard chemotherapy in the case of muscle-invasive tumors. Finally, they appear to decrease the risk of recurrence after initial BCG treatment failure in the case of non-muscle-invasive tumors. For these three diseases forms, numerous ongoing trials are striving to demonstrate checkpoint inhibitors value.

UR - http://www.scopus.com/inward/record.url?scp=85109012683&partnerID=8YFLogxK

M3 - Article

C2 - 34161004

AN - SCOPUS:85109012683

SN - 0035-2640

VL - 71

SP - 391

EP - 395

JO - Revue du Praticien

JF - Revue du Praticien

IS - 4

ER -

Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire

Abstract

Other files and links

Cite this